JPRN-UMIN000018659招募中未知
Inhibitory effects of tocilizumab on serum oxidative stress in patients with rheumatoid arthritis -comaparison with other biologic agents- - Inhibitory effects of tocilizumab on serum oxidative stress in patients with RA
Toho University School of Medicine0 个研究点目标入组 60 人开始时间: 2015年8月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. RA patients on remission or low disease activity 2. Patients who have recieved biologic agents 3. Patients who have suffered from severe infection disease or have high risk factors
研究者
相似试验
撤回
4 期
Effects of Tocilizumab (RoACTEMRA) on biomarkers in synovial tissue of patients with rheumatoid arthritisRheumatiod Arthritis10003816NL-OMON36162Academisch Medisch Centrum20
已完成
不适用
Effects of Tocilizumab on Bone Metabolism, RANKL, osteoprotegerin, DKK-1 and osteopontin in Rheumatoid Arthritis.Rheumatoid ArthritisJPRN-UMIN000016117Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine60
招募中
3 期
Evaluation of The effect of tocilizumab on patients with severe Covid 19IRCT20210408050899N1Ahvaz University of Medical Sciences15
招募中
3 期
Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patientsIRCT20200510047383N1Arak University of Medical Sciences100
已完成
2 期
Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20081027001411N4Tehran University of Medical Sciences40